AssetMark Inc
PDLI

AssetMark Inc’s PDL BioPharma, Inc. PDLI Stock Holding History

AssetMark Inc’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,581
Closed -$5K – 1500
2019
Q2 		$5K Buy
1,581
+421
+36% +$1.37K ﹤0.01% 1070
2019
Q1 		$4K Buy
1,160
+157
+16% +$530 ﹤0.01% 1104
2018
Q4 		$3K Sell
1,003
-728
-42% -$2K ﹤0.01% 1194
2018
Q3 		$5K Sell
1,731
-148
-8% -$363 ﹤0.01% 1188
2018
Q2 		$4K Sell
1,879
-59
-3% -$165 ﹤0.01% 1217
2018
Q1 		$6K Buy
1,938
+110
+6% +$300 ﹤0.01% 1143
2017
Q4 		$5K Buy
1,828
+1,683
+1,161% +$5.17K ﹤0.01% 1268
2017
Q3 		$0 Buy
145
+141
+3,525% +$392 ﹤0.01% 1705
2017
Q2 		$0 Buy
+4
New +$9 ﹤0.01% 1561
2017
Q1 		– Sell
-49
Closed – – 1544
2016
Q4 		$0 Buy
+49
New +$137 ﹤0.01% 1465

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return